The dyslipidemia that was observed in HFD‐fed hamsters improved with IMM‐H007 treatment without affecting food consumption, as evidenced by reduced serum levels of TGs, cholesterol, and FFAs, together with decreased levels of plasma insulin and transaminases. The gene discussed is INS; the disease is metabolic syndrome.